uniQure’s AMT-130 receives FDA Orphan Drug Designation in Huntington’s disease

22:02 EDT 16 Jun 2018 | European Biotechnology News

More From BioPortfolio on "uniQure’s AMT-130 receives FDA Orphan Drug Designation in Huntington’s disease"